HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 141 | 157 | 89.8% | |
| HF004 | 2020 | 172 | 194 | 88.7% | |
| HF006 | 2021 | 216 | 247 | 87.5% | |
| HF006 | 2022 | 231 | 239 | 96.7% | |
| HF006 | 2023 | 291 | 299 | 97.3% |
